(R) -Safinamide
(R) -Safinamide, the enantiomer of safinamide (HY-70057), can inhibit MAO-B with an IC50 value of 0.45 μM[1].
Product Specifications
CAS Number
[174756-44-6]
Product Name Alternative
FCE 28073; (R) -EMD 1195686
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Monoamine Oxidase
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/r-safinamide.html
Purity
99.89
Solubility
DMSO : ≥ 125 mg/mL
Smiles
FC1=CC=CC(COC2=CC=C(C=C2)CN[C@@H](C(N)=O)C)=C1
Molecular Formula
C17H19FN2O2
Molecular Weight
302.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Ledesma A E, et al. A combined theoretical and experimental study on the structure, vibrational, and electronic properties of antiparkinsonian drug safinamide[J]. SN Applied Sciences, 2020, 2 (11) : 1895.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
128333-PE 100 µL
IGF2BP2 (Insulin-like Growth Factor 2 mRNA-binding Protein 2, IGF2 mRNA-binding Protein 2, IMP-2, Hepatocellular Carcinoma Autoantigen p62, IGF-II mRNA-binding Protein 2, VICKZ Family Member 2, IMP2, VICKZ2) (PE)
Sign In for Pricing
View Details